Similarly, miglitol, an oral antidiabetic drug, demonstrated melanin synthesis inhibition in B16F10 melanoma cells by regulating PKA, MAPK, and GSK-3β/β-catenin signaling pathways, making it a promising ingredient for skin-whitening products [22]. Here, GSK3B is linked to melanoma.